Publication
Zika virus infection in Nicaraguan households
Downloadable Content
- Persistent URL
- Last modified
- 05/22/2025
- Type of Material
- Authors
- Language
- English
- Date
- 2018-05-01
- Publisher
- Public Library of Science
- Publication Version
- Copyright Statement
- © 2018 Burger-Calderon et al.
- License
- Final Published Version (URL)
- Title of Journal or Parent Work
- ISSN
- 1935-2727
- Volume
- 12
- Issue
- 5
- Start Page
- e0006518
- End Page
- e0006518
- Grant/Funding Information
- This research was funded by grants P01AI106695 (EH) and R01AI099631 (AB) from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health.
- The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
- Supplemental Material (URL)
- Abstract
- Zika virus (ZIKV) infection recently caused major epidemics in the Americas and is linked to congenital birth defects and Guillain-Barré Syndrome. A pilot study of ZIKV infection in Nicaraguan households was conducted from August 31 to October 21, 2016, in Managua, Nicaragua. We enrolled 33 laboratory-confirmed Zika index cases and their household members (109 contacts) and followed them on days 3–4, 6–7, 9–10, and 21, collecting serum/plasma, urine, and saliva specimens along with clinical, demographic, and socio-economic status information. Collected samples were processed by rRT-PCR to determine viral load (VL) and duration of detectable ZIKV RNA in human bodily fluids. At enrollment, 11 (10%) contacts were ZIKV rRT-PCR-positive and 23 (21%) were positive by IgM antibodies; 3 incident cases were detected during the study period. Twenty of 33 (61%) index households had contacts with ZIKV infection, with an average of 1.9 (range 1–6) positive contacts per household, and in 60% of these households, ≥50% of the members were positive for ZIKV infection. Analysis of clinical information allowed us to estimate the symptomatic to asymptomatic (S:A) ratio of 14:23 (1:1.6) among the contacts, finding 62% of the infections to be asymptomatic. The maximum number of days during which ZIKV RNA was detected was 7 days post-symptom onset in saliva and serum/plasma and 22 days in urine. Overall, VL levels in serum/plasma, saliva, and urine specimens were comparable, with means of 5.6, 5.3 and 4.5 log10copies/ml respectively, with serum attaining the highest VL peak at 8.1 log10copies/ml. Detecting ZIKV RNA in saliva over a similar time-period and level as in serum/plasma indicates that saliva could potentially serve as a more accessible diagnostic sample. Finding the majority of infections to be asymptomatic emphasizes the importance of silent ZIKV transmission and helps inform public health interventions in the region and globally.
- Author Notes
- Keywords
- Research Categories
- Health Sciences, Public Health
- Health Sciences, Medicine and Surgery
Tools
- Download Item
- Contact Us
-
Citation Management Tools
Relations
- In Collection:
Items
| Thumbnail | Title | File Description | Date Uploaded | Visibility | Actions |
|---|---|---|---|---|---|
|
|
Publication File - t3gc0.pdf | Primary Content | 2025-03-15 | Public | Download |